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Severe hypoglycemia developed during nonlethal Plasmodium chabaudi and lethal P. yoelii blood stage
malaria infection in mice, always in association with hyperinsulinemia. Supernatants of lethal P. yoelii
incubated overnight induced hypoglycemia and hyperinsulinemia in normal mice. In murine malaria,
hypoglycemia may be largely secondary to increased insulin secretion.
Hypoglycemia (blood glucose of <4 mmol/liter) is recog-
nized as a serious complication of Plasmodium falciparum
malaria (20), but the triggering mechanism is unclear. In
patients treated with quinine, it is usually attributed to the
hyperinsulinemic action of quinine (11, 19), though cases in
which hypoglycemia (10, 17) and hyperinsulinemia (10) pre-
ceded treatment have been reported. We recently showed,
using the murine malaria parasite P. yoelii, that a supernatant
of blood stage parasites incubated overnight induced hypogly-
cemia when injected into normal mice and that this could be
prevented by prior immunization with supernatant or with
phosphatidylinositol (15); we proposed that the "toxic anti-
gens" responsible were phospholipids similar to those we had
already shown to induce tumor necrosis factor (TNF) (1). It
was subsequently proposed by another laboratory that a glyco-
sylphosphatidylinositol molecule derived from P. falciparum
had similar activities (13). We also found, by measuring
lipogenesis and lipolysis in adipocytes in vitro, that these toxic
antigens appeared to synergize with low levels of insulin rather
than acting on their own (16). The way in which these
parasite-derived molecules induce hypoglycemia is not estab-
lished, but in view of the hyperinsulinemia reported in hypo-
glycemic malaria patients treated with quinine (11, 19), we
thought it worth investigating the role of insulin in the produc-
tion of hypoglycemia in our experimental animal models of
malaria.
Mice, parasites, and assays. We used 8- to 12-week-old
(C57BL x BALB/c)F1 mice bred in our department from
parent strains obtained from the National Institute for Medical
Research, London, England. Lipopolysaccharide-unresponsive
C3H/HeJ mice were obtained from Harlan Olac Ltd. (Bicester,
England). Outbred CD1 mice were obtained from Charles
River Ltd. (Kent, England). Mice were kept on a standard 12-h
light-12-h darkness cycle and pellet diet (RMI; SDS, Essex,
England). They had free access to food and water throughout
the experiment. The nonlethal strain of P. yoelii, 17X, was
donated by the London School of Hygiene and Tropical
Medicine. The lethal P. yoelii YM variant was obtained from A.
Holder, then at Wellcome Biotech. The P. chabaudi strain used
was the nonlethal AS strain, obtained from K. N. Brown,
NIMR. All parasites were maintained by blood Passage, and
infections were initiated intravenously with 10 parasitized
erythrocytes. Parasitemia was scored on Giemsa-stained tail
* Corresponding author. Mailing address: Department of Immunol-
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blood films. Parasite supernatants were prepared with the YM
lethal variant of P. yoelii, following overnight culture of para-
sitized blood in phosphate-buffered saline (pH 7.4) on a roller
at 37°C, as described previously (1). For the determination of
immunoreactive insulin (IRI), blood was collected from the
trunk in heparinized Eppendorf tubes following decapitation
of the mice. Plasma was separated by centrifugation and frozen
at -20°C. IRI concentrations were determined in 50-,ul vol-
umes by the double-antibody radioimmunoassay technique (7),
using antibody and 125I-labelled insulin (kit supplied by ICN
Biomedicals, Irvine, Calif.) and a crystalline rat insulin stan-
dard (Novo Research Institute, Bagsvaerd, Denmark), widely
used for mouse work (14). All samples were assayed in
duplicate. Glucose concentrations were determined enzymati-
cally on 10-,ul volumes of tail blood, collected between 10 a.m.
and midday, using Glucostix and an Ames Glucometer (Mile
Ltd., Stoke Poges, England). Measurements from more than
50 normal mice of both sexes gave a value of 7.0 ± 0.5
mmol/liter. Blood glucose levels millimoles per liter and
plasma IRI values (nanograms per milliliter) are expressed as
means ± standard errors of the mean (SEM). Statistical
significance was assessed by using analysis of variance
(ANOVA) or, when appropriate, Student's t test for paired
observations.
Hypoglycemia and hyperinsulinemia. Blood glucose was
measured daily during infection with nonlethal P. yoelii (17X),
lethal P. yoelii (YM), or P. chabaudi (Fig. la, b, and c).
Nonlethal P. yoelii did not induce hypoglycemia. With P. yoelii
YM, hypoglycemia occurred 1 to 2 days before death, when the
parasitemia was around 50%. With P. chabaudi, the mice
became severely hypoglycemic at days 10 to 12, at the time of
highest parasitemia (60%) and crisis, but recovered shortly
thereafter. Hypoglycemia was identical in C3H/HeJ mice (not
shown), suggesting that endotoxin was not a factor.
Before infection, mice had 2.5 ± 0.2 ng of insulin per ml in
their blood, which is within the expected range (18). During P.
yoelii YM infection, plasma IRI levels rose with the para-
sitemia, to reach the remarkably high level of 180 ng/ml on the
day before death (Fig. 2a). During P. chabaudi infection, IRI
levels rose to 90 ng/ml 11 days after infection, at a time when
parasitemia was about 60%, and fell as the mice recovered
(Fig. 2b). Thus, in both cases, blood glucose and insulin levels
were inversely correlated.
As reported previously (15), injection of parasite superna-
tants induced a significant fall of blood glucose in normal mice,
reaching a minimum at 4 to 6 h (P < 0.0001; Fig. 3a).
Supernatants of normal erythrocytes were weakly active or
negative. Four hours after injection of parasite supernatants,
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FIG. 2. Plasma IRI levels in groups of 8 to 10 mice infected with
lethal P. yoelii (a) or P. chabaudi (b). Each column represents the mean
± SEM. ANOVA shows a significant effect of the infection compared
with uninfected (control) values: *P < 0.05 and **P < 0.0001. The
mean percent parasitemia is given above each column.
there was a significant increase in plasma insulin levels from
2.2 ± 0.2 to 5.2 ± 0.7 ng/ml (P < 0.01; Fig. 3b). The
supernatants themselves gave readings of 0 to 0.2 ng/ml, so the
amount of insulin contained in 0.5 ml (the injected dose) could
not account for the blood levels detected.
The exact mechanism(s) of hypoglycemia in malaria remains
controversial, but insulin appears to play a role in murine
models, according to the present study. It was noteworthy that
hypoglycemia and hyperinsulinemia were only detected when
the parasitemia exceeded about 50%, which may explain why
they were not seen in the nonlethal P. yoelii infection, when
parasitemia rose to only about 20%. Such levels are rare in
human malaria, although if parasites sequester in the pancreas,
as they do in the brain, the local concentration could be
relatively high.
It has been suggested that high levels of circulating TNF are
responsible for much of the pathology of malaria (6). Infusion
of TNF in animals has been reported to increase glucose
uptake but also to cause a decrease in serum insulin (3).
Moreover, injection of a neutralizing monoclonal antibody
FIG. 1. Blood glucose levels during infection of (C57BL x BALB/
c)F1 mice with nonlethal P. yoelii 17X (a), lethal P. yoelii YM (b) and
(c) P. chabaudi AS (c). Values are means ± SEM (six to nine mice per
experiment). ANOVA shows a significant effect of lethal P. yoelii
infection compared with uninfected (day 0) values, *P < 0.05 and **P
< 0.0001, and a significant effect of P. chabaudi infection, *P < 0.05
and **P < 0.0001. No significant effect is seen iwth nonlethal P. yoelii.
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FIG. 3. Blood glucose (a) and plasma IRI (b) levels in normal mice
after injection of 0.5 ml of lethal P. yoelii parasite supernatant. The
results are pooled from three experiments with different supernatants
(three mice per experiment). Values are means ± SEM. ANOVA
shows a significant effect of the supernatant compared with normal
(time zero; control) values: *P < 0.0001.
against murine TNF failed to attenuate hypoglycemia induced
by our malaria supernatants (15), so it seems unlikely that TNF
plays a major role in the marked hyperinsulinemia we ob-
served. We are currently investigating the possibility that
malaria-derived molecules may directly stimulate insulin secre-
tion from pancreatic islets, as appears to be the case with a
preparation derived from Bordetella pernussis which increases
insulin secretion and lowers blood glucose in normal but not
pancreatectomized dogs (22); a similar effect is seen in B.
pentussis-infected mice (14) and in rats injected with Salmonella
endotoxin (21) or with quinine (8). The higher levels of insulin
associated with hypoglycemia in the infected mice than in the
supernatant-injected mice (Fig. 2a versus 3b) could be ex-
plained by the development of insulin resistance during infec-
tion (2), possibly due to TNF (4), but it is possible that factors
other than insulin also contribute to hypoglycemia.
There are many differences between murine and human
malaria, but it might be of value to measure plasma insulin in
a larger number of patients with severe malaria, particularly in
those with high parasitemia. If there is indeed a significant
subgroup in which hyperinsulinemia is a feature, therapy might
be directed at this. Indeed, in one study, somatostatin analog
(SMS 201-995) was successfully used to control hyperinsuline-
mia in quinine-treated patients (11). Treatment along these
lines might be more logical than injection of glucose, which is
likely to further stimulate insulin secretion. Hypoglycemia with
normal plasma insulin is more likely to be due to depletion of
liver glycogen or glucose starvation, and here, of course,
glucose therapy would be indicated.
Hypoglycemia has been reported previously in mice (12) and
rats (9) infected with P. berghei and in rhesus monkeys with P.
knowlesi (5) and P. coatneyi infection (2). However, ours
appears to be the first report of self-limiting hypoglycemia
during infection with nonlethal P. chabaudi and the first to
show the expected correlation with insulin levels, namely,
hyperinsulinemia at the time of hypoglycemia. This may there-
fore be a good model in which to study the effects of malaria on
glucose homeostasis.
We thank E. D. Saggerson and T. Rademacher for helpful discus-
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